News & Insights

This section provides updates on Egetis Therapeutics, including regulatory announcements, corporate news, media coverage and perspectives related to rare diseases and scientific developments.

Content is presented in clearly defined categories to distinguish between regulatory disclosures, third-party coverage and company perspectives.

Please find more information below:

Press releases Latest From LinkedIn

Subscribe to Updates

Get press releases and reports from Egetis Therapeutics delivered straight to your inbox.

Subscribe to press releases and reports via email.

Check the types of releases you want to subscribe to.

Press releases
Reports
Other news

Check the languages you want to subscribe to.

Swedish
English

A real email address must be provided.

An email has been sent to confirm your subscription.

Press releases

This section contains official press releases issued by Egetis. These announcements include regulatory updates, corporate developments and information disclosed in accordance with applicable market regulations.

Explore